• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锥体外系体征和精神病作为阿尔茨海默病认知和功能衰退、入住养老院及死亡预测指标的效用:预测研究的前瞻性分析

Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study.

作者信息

Stern Y, Albert M, Brandt J, Jacobs D M, Tang M X, Marder K, Bell K, Sano M, Devanand D P, Bylsma F

机构信息

Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY.

出版信息

Neurology. 1994 Dec;44(12):2300-7. doi: 10.1212/wnl.44.12.2300.

DOI:10.1212/wnl.44.12.2300
PMID:7991116
Abstract

OBJECTIVE

To examine whether either extrapyramidal signs or psychotic features are associated with more rapid progression of Alzheimer's disease.

BACKGROUND

It has been unclear whether extrapyramidal signs and psychosis are predictors of faster course or are simply late signs.

METHODS

Two hundred thirty-six patients with mild Alzheimer's disease were recruited in three cities and followed semiannually.

RESULTS

Using Cox proportional hazards models that adjusted for age, sex, disease severity, and estimated duration of illness at study entry, the presence of extrapyramidal signs at entry was associated with higher relative risk (RR) of reaching moderate cognitive (RR = 2.35, 95% CI = 1.12 to 4.92) or functional (RR = 2.31, 95% CI = 1.37 to 3.90) severity, nursing home entry (RR = 2.51, 95% CI = 1.32 to 4.76), or death (RR = 3.04, 95% CI = 1.31 to 7.05). Psychosis predicted only the functional end point (RR = 1.85, 95% CI = 1.18 to 2.90). Using regression models, modified Mini-Mental State scores declined 1.30 points (95% CI = 0.16 to 2.44) per 6-month interval, more among patients with than those without extrapyramidal signs; patients with psychosis declined 1.15 (95% CI = 0.52 to 1.77) more mMMS points per interval.

CONCLUSIONS

This study confirms extrapyramidal signs and psychosis as robust predictors of disease end points and rapid progression in Alzheimer's disease.

摘要

目的

研究锥体外系症状或精神病性症状是否与阿尔茨海默病的更快进展相关。

背景

锥体外系症状和精神病是否是病程更快的预测因素,或者仅仅是晚期症状,目前尚不清楚。

方法

在三个城市招募了236例轻度阿尔茨海默病患者,并每半年进行一次随访。

结果

使用Cox比例风险模型,对年龄、性别、疾病严重程度以及研究入组时估计的病程进行校正后,入组时存在锥体外系症状与达到中度认知(相对风险[RR]=2.35,95%可信区间[CI]=1.12至4.92)或功能(RR=2.31,95%CI=1.37至3.90)严重程度、入住养老院(RR=2.51,95%CI=1.32至4.76)或死亡(RR=3.04,95%CI=1.31至7.05)的相对风险更高相关。精神病仅预测功能终点(RR=1.85,95%CI=1.18至2.90)。使用回归模型,改良简易精神状态评分每6个月间隔下降1.30分(95%CI=0.16至2.44),有锥体外系症状的患者下降幅度大于无锥体外系症状的患者;有精神病的患者每间隔下降的改良简易精神状态评分多1.15分(95%CI=0.52至1.77)。

结论

本研究证实锥体外系症状和精神病是阿尔茨海默病疾病终点和快速进展的有力预测因素。

相似文献

1
Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study.锥体外系体征和精神病作为阿尔茨海默病认知和功能衰退、入住养老院及死亡预测指标的效用:预测研究的前瞻性分析
Neurology. 1994 Dec;44(12):2300-7. doi: 10.1212/wnl.44.12.2300.
2
Predicting time to nursing home care and death in individuals with Alzheimer disease.预测阿尔茨海默病患者进入养老院护理的时间和死亡时间。
JAMA. 1997 Mar 12;277(10):806-12.
3
Predictors of nursing home admission among Alzheimer's disease patients with psychosis and/or agitation.阿尔茨海默病伴精神病和/或激越患者入住养老院的预测因素。
Int Psychogeriatr. 2011 Feb;23(1):44-53. doi: 10.1017/S1041610210000244. Epub 2010 Mar 10.
4
The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease.可能患有阿尔茨海默病的患者中,常规和非典型抗精神病药物的长期影响。
Am J Psychiatry. 2013 Sep;170(9):1051-8. doi: 10.1176/appi.ajp.2013.12081046.
5
Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease.锥体外系症状和精神症状预示着阿尔茨海默病患者认知功能衰退更快。
Arch Neurol. 1994 Jul;51(7):676-81. doi: 10.1001/archneur.1994.00540190056015.
6
EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease.脑电图频谱异常和精神病作为可能的阿尔茨海默病认知和功能衰退的预测指标。
Neurology. 1997 Jun;48(6):1521-5. doi: 10.1212/wnl.48.6.1521.
7
Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition.通过胆碱酯酶抑制改变阿尔茨海默病自然病程中有临床意义的转归。
J Am Geriatr Soc. 2005 Jan;53(1):83-7. doi: 10.1111/j.1532-5415.2005.53015.x.
8
Prognosis of an abnormal one-leg balance in community-dwelling patients with Alzheimer's disease: a 2-year prospective study in 686 patients of the REAL.FR study.社区居住的阿尔茨海默病患者单腿平衡异常的预后:REAL.FR 研究中 686 例患者的 2 年前瞻性研究。
J Am Med Dir Assoc. 2012 May;13(4):407.e1-6. doi: 10.1016/j.jamda.2011.11.003. Epub 2012 Jan 9.
9
Neuropsychological predictors of dependency in patients with Alzheimer disease.阿尔茨海默病患者依赖的神经心理学预测因素
Neurology. 2005 Mar 22;64(6):1027-31. doi: 10.1212/01.WNL.0000154529.53488.30.
10
Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease.精神科药物与异常行为作为可能的阿尔茨海默病病情进展的预测因素。
Arch Neurol. 1999 Oct;56(10):1266-72. doi: 10.1001/archneur.56.10.1266.

引用本文的文献

1
Neural basis of motor symptoms in Alzheimer's disease: role of regional tau burden and cognition.阿尔茨海默病运动症状的神经基础:区域tau蛋白负荷与认知的作用
Alzheimers Dement. 2025 Aug;21(8):e70598. doi: 10.1002/alz.70598.
2
An artificial intelligence-derived metabolic network predicts psychosis in Alzheimer's disease.人工智能衍生的代谢网络可预测阿尔茨海默病中的精神病。
Brain Commun. 2025 Apr 25;7(3):fcaf159. doi: 10.1093/braincomms/fcaf159. eCollection 2025.
3
Psychosis in Neurocognitive Disorder Among Ethnoculturally Diverse Older Persons.
不同种族文化背景的老年人神经认知障碍中的精神病
Neurol Clin Pract. 2025 Jun;15(3):e200467. doi: 10.1212/CPJ.0000000000200467. Epub 2025 Apr 25.
4
Exploring Potential Medications for Alzheimer's Disease with Psychosis by Integrating Drug Target Information into Deep Learning Models: A Data-Driven Approach.通过将药物靶点信息整合到深度学习模型中探索用于伴有精神病的阿尔茨海默病的潜在药物:一种数据驱动方法
Int J Mol Sci. 2025 Feb 14;26(4):1617. doi: 10.3390/ijms26041617.
5
Predictors for survival in patients with Alzheimer's disease: a large comprehensive meta-analysis.阿尔茨海默病患者生存的预测因素:一项大型综合荟萃分析。
Transl Psychiatry. 2024 Apr 10;14(1):184. doi: 10.1038/s41398-024-02897-w.
6
Neuropsychiatric Symptoms and Trajectories of Dependence and Cognition in a Sample of Community-dwelling Older Adults with Dementia.社区居住的老年痴呆症患者的神经精神症状与依赖和认知轨迹。
Curr Alzheimer Res. 2023;20(6):409-419. doi: 10.2174/1567205020666230908163414.
7
A Brief Review on the Potential of Psychedelics for Treating Alzheimer's Disease and Related Depression.迷幻剂治疗阿尔茨海默病及相关抑郁症的潜力简述。
Int J Mol Sci. 2023 Aug 7;24(15):12513. doi: 10.3390/ijms241512513.
8
Costs During the Last Five Years of Life for Patients with Clinical and Pathological Confirmed Diagnosis of Lewy Body Dementia and Alzheimer's Disease.临床和病理确诊的路易体痴呆和阿尔茨海默病患者生命最后五年的费用。
J Alzheimers Dis. 2023;92(2):457-466. doi: 10.3233/JAD-221021.
9
Potential beneficial effects of masupirdine (SUVN-502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses.马苏皮定(SUVN-502)对中度阿尔茨海默病患者激越/攻击和精神病的潜在有益作用:探索性事后分析。
Int J Geriatr Psychiatry. 2022 Oct;37(10). doi: 10.1002/gps.5813.
10
Prazosin for the management of behavioural and psychological symptoms of dementia.哌唑嗪用于治疗痴呆的行为和心理症状。
Drugs Context. 2022 Jul 1;11. doi: 10.7573/dic.2022-3-3. eCollection 2022.